The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
Year: 2016
Type: review
Source: Pharmacology & Therapeutics
Author: Hermann Koepsell
Institution: University of Würzburg
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2535160676
